Skip to content

The Effect of Preoperative Frailty on Postoperative Cognitive Function in Patients Undergoing Liver Transplantation

The Effect of Preoperative Frailty on Postoperative Cognitive Function in Patients Undergoing Liver Transplantation - The Effects of Preoperative Frailty on Postoperative Delirium in Patients Undergoing Liver Transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600130313
Enrollment
Unknown
Registered
2026-08-18
Start date
2026-08-24
Completion date
Unknown
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Delirium

Interventions

Non-decay group:None

Sponsors

The Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years, scheduled to undergo allogeneic liver transplantation (including deceased donor liver transplantation and living donor liver transplantation) at our hospital. 2. Preoperative cognitive function is normal (MMSE score: >=17 for illiterate individuals, >=20 for primary school education, and >=24 for middle school education or above). 3. Able to cooperate with preoperative ultrasound-based sarcopenia, frailty, and cognitive function assessments. 4. Informed consent obtained and signed by the patient or their legally authorized representative.

Exclusion criteria

Exclusion criteria: 1. Preoperatively diagnosed with cognitive impairment, dementia, psychiatric disorders (e.g., depression, schizophrenia, etc.), or neurological diseases (e.g., cerebral hemorrhage, cerebral infarction, intracranial tumors, etc.). 2. Preoperative presence of severe hepatic encephalopathy (grade III or above) or impaired consciousness. 3. Presence of lesions in the target muscle for assessment (e.g., muscle tumors, severe myositis, unhealed muscle tears after trauma, etc.) that may affect ultrasound evaluation results. 4. Prior history of organ transplantation or malignant tumors (except for patients with primary hepatocellular carcinoma who underwent liver transplantation without distant metastasis). 5. Severe infection, massive hemorrhage, or acute cardiovascular or cerebrovascular events within 2 weeks before surgery. 6. Pregnant or breastfeeding women. 7. Severe communication impairments (e.g., hearing or speech disorders) that prevent cooperation with scale assessments, or a history of long-term preoperative opioid dependence. 8. Refusal to participate in this study or inability to complete postoperative follow-up.

Design outcomes

Primary

MeasureTime frame
Postoperative Delirium;

Secondary

MeasureTime frame
Pretransplant frailty status;Preoperative cognitive function;Preoperative sarcopenia status;The levels of indicators such as CRP, IL-6, and TNF-a;Tube removal time;Time off the ventilator;ICU stay time;Complications that occur within 30 days after surgery;

Countries

China

Contacts

Public ContactLiu Aijie

The Affiliated Hospital of Qingdao University

clara_2074@163.com+86 532 82915820

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026